These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. Weekers F, Michalaki M, Coopmans W, Van Herck E, Veldhuis JD, Darras VM, Van den Berghe G. Endocrinology; 2004 Jan; 145(1):205-13. PubMed ID: 14551231 [Abstract] [Full Text] [Related]
24. The dynamic neuroendocrine response to critical illness. Langouche L, Van den Berghe G. Endocrinol Metab Clin North Am; 2006 Dec; 35(4):777-91, ix. PubMed ID: 17127146 [Abstract] [Full Text] [Related]
25. Thyroid axis function and dysfunction in critical illness. Mebis L, Van den Berghe G. Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):745-57. PubMed ID: 21925075 [Abstract] [Full Text] [Related]
26. [Hypothalamo-hypophyseal-thyroid axis in recruits and soldiers with male hypogonadism]. Tomov T, Ankov V. Vutr Boles; 1980 Oct; 19(5):53-61. PubMed ID: 6777988 [Abstract] [Full Text] [Related]
27. Changes within the thyroid axis during the course of critical illness. Mebis L, Debaveye Y, Visser TJ, Van den Berghe G. Endocrinol Metab Clin North Am; 2006 Dec; 35(4):807-21, x. PubMed ID: 17127148 [Abstract] [Full Text] [Related]
28. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. Van den Berghe G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD, Bowers CY, Bouillon R. J Clin Endocrinol Metab; 1999 Apr; 84(4):1311-23. PubMed ID: 10199772 [Abstract] [Full Text] [Related]
31. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I. Sjögren K, Jansson JO, Isaksson OG, Ohlsson C. Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852 [Abstract] [Full Text] [Related]
32. Dopamine suppresses pituitary function in infants and children. Van den Berghe G, de Zegher F, Lauwers P. Crit Care Med; 1994 Nov; 22(11):1747-53. PubMed ID: 7956277 [Abstract] [Full Text] [Related]
33. Changes within the GH/IGF-I/IGFBP axis in critical illness. Mesotten D, Van den Berghe G. Crit Care Clin; 2006 Jan; 22(1):17-28, v. PubMed ID: 16399017 [Abstract] [Full Text] [Related]
34. Treatment with GH and IGF-1 in critical illness. Teng Chung T, Hinds CJ. Crit Care Clin; 2006 Jan; 22(1):29-40, vi. PubMed ID: 16399018 [Abstract] [Full Text] [Related]
35. Hypothalamic thyroid hormone feedback in health and disease. Fliers E, Alkemade A, Wiersinga WM, Swaab DF. Prog Brain Res; 2006 Jan; 153():189-207. PubMed ID: 16876576 [Abstract] [Full Text] [Related]
37. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Giavoli C, Porretti S, Ferrante E, Cappiello V, Ronchi CL, Travaglini P, Epaminonda P, Arosio M, Beck-Peccoz P. Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926 [Abstract] [Full Text] [Related]
39. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. Kim E, Sohn S, Lee M, Jung J, Kineman RD, Park S. J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552 [Abstract] [Full Text] [Related]